Roche to acquire TIB Molbiol Group to expand PCR-test portfolio
Roche signs a definitive share purchase agreement with TIB Molbiol Group to expand PCR-test portfolio against infectious diseases.
List view / Grid view
Roche signs a definitive share purchase agreement with TIB Molbiol Group to expand PCR-test portfolio against infectious diseases.
A recent report has presented an argument for updating vaccine development during health emergencies to increase efficiency.
Researchers report on GS-5734, a promising experimental broad-spectrum antiviral drug...